Ilyang Pharmaceutical Co.,Ltd Capital Reinvestment Ratio
Ilyang Pharmaceutical Co.,Ltd capital reinvestment ratio. Ilyang Pharmaceutical Co.,Ltd (007575) has a Capital Reinvestment Ratio of 0.07x as of March 2026, meaning it reinvests 0% of its operating cash flow (₩26.51 Billion) in capital expenditures (₩1.74 Billion). Check 007575 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Ilyang Pharmaceutical Co.,Ltd (2014–2025)
Capital reinvestment ratio of Ilyang Pharmaceutical Co.,Ltd from 2014 to 2025. This chart tracks Ilyang Pharmaceutical Co.,Ltd's Capital Reinvestment Ratio across 12 annual periods. Also explore 007575 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Ilyang Pharmaceutical Co.,Ltd Capital Reinvestment Ratio by Year (2014–2025)
Ilyang Pharmaceutical Co.,Ltd capital reinvestment ratio by year from 2014 to 2025. For the full cash flow conversion analysis, see Ilyang Pharmaceutical Co.,Ltd (007575) cash conversion ratio.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.87x | ₩12.04 Billion | ₩10.44 Billion | ▼ -88.0% |
| 2024 | 7.23x | ₩5.61 Billion | ₩40.62 Billion | ▲ +1448.0% |
| 2023 | 0.47x | ₩14.62 Billion | ₩6.83 Billion | ▲ +242.8% |
| 2022 | 0.14x | ₩29.94 Billion | ₩4.08 Billion | ▼ -29.2% |
| 2021 | 0.19x | ₩67.02 Billion | ₩12.91 Billion | ▲ +8.8% |
| 2020 | 0.18x | ₩57.48 Billion | ₩10.17 Billion | ▲ +194.7% |
| 2019 | 0.06x | ₩36.19 Billion | ₩2.17 Billion | ▼ -14.1% |
| 2018 | 0.07x | ₩22.12 Billion | ₩1.55 Billion | ▼ -44.5% |
| 2017 | 0.13x | ₩30.03 Billion | ₩3.78 Billion | ▼ -67.0% |
| 2016 | 0.38x | ₩26.98 Billion | ₩10.31 Billion | ▼ -4.3% |
| 2015 | 0.40x | ₩40.27 Billion | ₩16.07 Billion | ▼ -46.5% |
| 2014 | 0.75x | ₩18.63 Billion | ₩13.89 Billion | — |